Animal Healthcare Market (By Animal Type: Production Animal, Companion Animal; By Product: Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, Equipment and Disposables; By Distribution Channel: Retail Pharmacy, E-commerce, Hospital Pharmacy; By End Use; By Treatments) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global animal healthcare market size was estimated at USD 54 billion in 2022 and is expected to surpass around USD 85.07 billion by 2032, poised to grow at a compound annual growth rate (CAGR) of 4.70% from 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. animal healthcare market size was valued at US$ 11.34 billion in 2022 and is predicted to reach around US$ 18.21 billion by 2032, growing at a CAGR of 4.90% between 2023 to 2032.
North America region accounted revenue share of 30% in 2022. This is attributed to a wide range of concrete initiatives taken by government animal welfare organizations that are continually trying to enhance animal health. In addition, technological advances, an increase in the number of pet owners, and an increase in the frequency of zoonotic diseases are likely to drive the animal healthcare market expansion in this region.
Asia-Pacific, on the other hand, is expected to develop at the fastest rate during the forecast period. This region’s rapid growth is thought to be the result of constant research and development investments by major companies in the animal healthcare market as well as their efforts to sell branded and generic treatments at affordable rates.
Animal healthcare entails conserving, directing, and safeguarding animals from a variety of diseases as well as providing them with essential veterinary treatments in order to extend their lives and increase their yield. The global animal healthcare market is available in two types. The key drivers of demand in the animal healthcare market are rising meat and milk consumption worldwide. Aside from that, growing foodborne and zoonotic diseases as well as the rising trend of pet adoption are all driving the animal healthcare market growth. The natural products are in high demand and food processors are in high demand and food processors want transparent labelling, which is expected to fuel demand in the animal healthcare market expansion during the forecast period.
A large growth in the demand for protein foods as well as an increase in the occurrence of food borne and zoonotic diseases around the world are driving the global animal healthcare market. The key market players have responded by developing outstanding medications and vaccines as a result of the remarkable decrease in diseases occurrence. In addition, as the number of animals has increased, global demand in proper animal health monitoring technologies has grown. The increased government activities in many locations have heightened animal healthcare and sparked a surge in veterinary vaccine interest. On account of different benefits such as convenience and cheaper pricing for ordered pharmaceuticals, several developed countries are functioning as the focal point for the rise of online pharmacy usage. Investing in research and development projects to provide improved product offerings as well as acceptance of innovative technologies by key players to alter the animal healthcare market, have all contributed to the worldwide animal healthcare market growth.
| Report Coverage | Details |
| Animal Healthcare Market Size in 2022 | USD 54 Billion |
| Animal Healthcare Market Size by 2032 | USD 85.07 Billion |
| Animal Healthcare Market Growth Rate from 2023 to 2032 | CAGR of 4.70% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Animal Type, By Product, By Distribution Channel, By End Use, and By Treatments |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
The governments all across the world are focusing on enacting and enforcing stronger animal healthcare legislation and regulations. The animal healthcare market growth will be supported by animal adoption and protection, improved treatment facilities, emergency healthcare systems, vaccination drives, immunization programs for animal healthcare, and birth control. The financial support for animal shelters as well as funding for multiple veterinary research laboratories dedicated to containing advanced zoonotic and foodborne diseases, will help the animal healthcare market growth significantly.
Following the COVID-19 pandemic, telehealth and eHealth applications are creating lucrative opportunities for the growth of the global animal healthcare market. As animal medicine testing is being scrutinized, the market players should rely on surveys and data collection from pet and production animal owners to develop drug formulations. The worldwide animal healthcare market is growing due to an increase in global consumption of meat and milk products as well as novel diseases in animals and their potential transmission to humans through product consumption and companionship. Animals are currently being affected by a number of new diseases. These infections can cause the animal to get extremely unwell or possibly kill it. As a result, the animal’s owner must have the essential treatments to cure the animals.
In 2022, the pharmaceutical segment accounted market share of 34%. On the basis of continuing improvements in veterinary pharmaceuticals, it is expected to maintain its dominant position during the projection period. The anti-inflammatory medications, antibiotics, parasiticides, and other pharmaceuticals are among the most common.
The veterinary diagnostics segment, on the other hand, is predicted to develop at the quickest rate in the future years. The expanding number of veterinary practitioners and their incomes in industrialized nations, rising animal health expenditure, and increased zoonotic diseases incidence are all contributing to segment expansion.
The others segment is expected to registered growth at a CAGR of 16% from 2023 to 2032.
The production animal segment dominated the market in 2022 with a revenue share of 64.50%. The segment’s significant market share can be attributed to government healthcare organizations’ worldwide concern for food safety and sustainability.
The companion animal segment is the fastest growing segment of the animal healthcare market in 2023. The policymakers in numerous countries are aiming for overall food security, which encourages large scale food production and increases animal husbandry.
The hospital pharmacies segment garnered a revenue share of around 52% in 2022. The segment’s growth has been aided by an increase in the number of hospital pharmacies as well as a high procedural volume as a result of frequent readmission of pets for treatment.
The retail pharmacies segment is fastest growing segment of the animal healthcare market in 2023. For the distribution of drugs and vaccines, major producers rely solely on certified veterinarians and authorized wholesalers.
In 2022, the veterinary hospitals and clinics segment accounted revenue share of around 73.5%. The segment’s leading market share is due to a variety of applications including clinical pathology, toxicological tests, and therapy. In veterinary hospitals and clinics, the provision of a wide range of therapeutic and diagnostic solutions is a high impact rendering growth driver for this industry.
The point of care testing/in-house testing segment, on the other hand, is predicted to develop at the quickest rate in the future years. The climatic change and globalization are predicted to increase the frequency of zoonotic illnesses, which will boost demand for diagnostic procedures which will drive the point of care testing/in-house testing segment in the next years.
Segments Covered in the Report
By Animal Type
By Product
By Distribution Channel
By End Use
By Treatments
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Animal Healthcare Market
5.1. COVID-19 Landscape: Animal Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Animal Healthcare Market, By Animal Type
8.1. Animal Healthcare Market, by Animal Type, 2023-2032
8.1.1. Production Animal
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Companion Animal
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Animal Healthcare Market, By Product Type
9.1. Animal Healthcare Market, by Product Type, 2023-2032
9.1.1. Vaccines
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Pharmaceuticals
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Feed Additives
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Diagnostics
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Equipment and Disposables
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Animal Healthcare Market, By Distribution Channel
10.1. Animal Healthcare Market, by Distribution Channel Type, 2023-2032
10.1.1. Retail Pharmacy
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. E-commerce
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Hospital Pharmacy
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Animal Healthcare Market, By End Use
11.1. Animal Healthcare Market, by End Use Type, 2023-2032
11.1.1. Reference Laboratories
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Point of care testing/ in-house testing
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Veterinary Hospitals & Clinics
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Animal Healthcare Market, By Treatments Type
12.1. Animal Healthcare Market, by Treatments, 2023-2032
12.1.1. Allergies
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Arthritis
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Gastrointestinal Disease
12.1.3.1. Market Revenue and Forecast (2020-2032)
12.1.4. Difficult Dermatology Cases
12.1.4.1. Market Revenue and Forecast (2020-2032)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Animal Healthcare Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Animal (2020-2032)
13.1.2. Market Revenue and Forecast, by Product (2020-2032)
13.1.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.4. Market Revenue and Forecast, by End Use (2020-2032)
13.1.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Animal (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Product (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.6.4. Market Revenue and Forecast, by End Use (2020-2032)
13.1.7. Market Revenue and Forecast, by Treatments (2020-2032)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Animal (2020-2032)
13.1.8.2. Market Revenue and Forecast, by Product (2020-2032)
13.1.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.8.4. Market Revenue and Forecast, by End Use (2020-2032)
13.1.8.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Animal (2020-2032)
13.2.2. Market Revenue and Forecast, by Product (2020-2032)
13.2.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.4. Market Revenue and Forecast, by End Use (2020-2032)
13.2.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Animal (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Product (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.7. Market Revenue and Forecast, by End Use (2020-2032)
13.2.8. Market Revenue and Forecast, by Treatments (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Animal (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Product (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.10. Market Revenue and Forecast, by End Use (2020-2032)
13.2.11. Market Revenue and Forecast, by Treatments (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Animal (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Product (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.12.4. Market Revenue and Forecast, by End Use (2020-2032)
13.2.13. Market Revenue and Forecast, by Treatments (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Animal (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Product (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.14.4. Market Revenue and Forecast, by End Use (2020-2032)
13.2.15. Market Revenue and Forecast, by Treatments (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Animal (2020-2032)
13.3.2. Market Revenue and Forecast, by Product (2020-2032)
13.3.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.4. Market Revenue and Forecast, by End Use (2020-2032)
13.3.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Animal (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Product (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.6.4. Market Revenue and Forecast, by End Use (2020-2032)
13.3.7. Market Revenue and Forecast, by Treatments (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Animal (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Product (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.8.4. Market Revenue and Forecast, by End Use (2020-2032)
13.3.9. Market Revenue and Forecast, by Treatments (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Animal (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Product (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.10.4. Market Revenue and Forecast, by End Use (2020-2032)
13.3.10.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Animal (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Product (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.11.4. Market Revenue and Forecast, by End Use (2020-2032)
13.3.11.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Animal (2020-2032)
13.4.2. Market Revenue and Forecast, by Product (2020-2032)
13.4.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.4. Market Revenue and Forecast, by End Use (2020-2032)
13.4.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Animal (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Product (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.6.4. Market Revenue and Forecast, by End Use (2020-2032)
13.4.7. Market Revenue and Forecast, by Treatments (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Animal (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Product (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.8.4. Market Revenue and Forecast, by End Use (2020-2032)
13.4.9. Market Revenue and Forecast, by Treatments (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Animal (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Product (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.10.4. Market Revenue and Forecast, by End Use (2020-2032)
13.4.10.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Animal (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Product (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.11.4. Market Revenue and Forecast, by End Use (2020-2032)
13.4.11.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Animal (2020-2032)
13.5.2. Market Revenue and Forecast, by Product (2020-2032)
13.5.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.4. Market Revenue and Forecast, by End Use (2020-2032)
13.5.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Animal (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Product (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.6.4. Market Revenue and Forecast, by End Use (2020-2032)
13.5.7. Market Revenue and Forecast, by Treatments (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Animal (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Product (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.8.4. Market Revenue and Forecast, by End Use (2020-2032)
13.5.8.5. Market Revenue and Forecast, by Treatments (2020-2032)
Chapter 14. Company Profiles
14.1. Elanco
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Bayer
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Dechra Pharmaceuticals
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Neogen
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Boehringer Ingelheim
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Merck & Co, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Zoetis
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Nutreco N.V.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Virbac
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Vetquinol S.A.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample